<DOC>
	<DOCNO>NCT00700076</DOCNO>
	<brief_summary>Org 25935 new putative antipsychotic agent develop N.V. Organon.The primary objective study investigate effect Org 25935 ketamine-induced impairment immediate recall .</brief_summary>
	<brief_title>Pilot Study ORG 25935 Modulation Ketamine-induced Behavioral Cognitive Effects Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Ketamine</mesh_term>
	<criteria>Male , 18 55 year History sensitivity/idiosyncrasy drug use study chemically related compound excipients may employ study unknown drug use past .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>ORG 25935</keyword>
	<keyword>Ketamine</keyword>
	<keyword>healthy subject</keyword>
</DOC>